David Jakeman - Net Worth and Insider Trading
David Jakeman Net Worth
The estimated net worth of David Jakeman is at least $134,496 dollars as of 2023-09-27. David Jakeman is the Principal Accounting Officer of Chimerix Inc and owns about 136,752 shares of Chimerix Inc (CMRX) stock worth over $134,496. Details can be seen in David Jakeman's Latest Holdings Summary section.
Transaction Summary of David Jakeman
David Jakeman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Jakeman owns 1 companies in total, including Chimerix Inc (CMRX) .
Click here to see the complete history of David Jakeman’s form 4 insider trades.
Insider Ownership Summary of David Jakeman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMRX | Chimerix Inc | 2019-06-20 | Principal Accounting Officer |
David Jakeman Latest Holdings Summary
David Jakeman currently owns a total of 1 stock. David Jakeman owns 136,752 shares of Chimerix Inc (CMRX) as of January 26, 2023, with a value of $134,496.
Latest Holdings of David Jakeman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CMRX | Chimerix Inc | 2023-01-26 | 136,752 | 0.98 | 134,496 |
Holding Weightings of David Jakeman
David Jakeman Form 4 Trading Tracker
According to the SEC Form 4 filings, David Jakeman has made a total of 7 transactions in Chimerix Inc (CMRX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Chimerix Inc is the sale of 3,230 shares on January 26, 2023, which brought David Jakeman around $5,685.
Insider Trading History of David Jakeman
- 1
David Jakeman Trading Performance
David Jakeman Ownership Network
Ownership Network List of David Jakeman
Ownership Network Relation of David Jakeman
David Jakeman Owned Company Details
What does Chimerix Inc do?
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.
Who are the key executives at Chimerix Inc?
David Jakeman is the Principal Accounting Officer of Chimerix Inc. Other key executives at Chimerix Inc include Chief Medical Officer Allen S. Melemed , 10 percent owner Cantex Pharmaceuticals, Inc. , and director & Chief Executive Officer Michael A. Sherman .
Chimerix Inc (CMRX) Insider Trades Summary
Over the past 18 months, David Jakeman made 2 insider transaction in Chimerix Inc (CMRX) with a net sale of 7,630. Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 80,000 shares made by Fred A Middleton , a net purchase of 28,000 shares made by Martha J Demski , and a net purchase of 87,000 shares made by Michael A. Sherman .
In summary, during the past 3 months, insiders sold 0 shares of Chimerix Inc (CMRX) in total and bought 20,000 shares, with a net purchase of 20,000 shares. During the past 18 months, 7,630 shares of Chimerix Inc (CMRX) were sold and 218,750 shares were bought by its insiders, resulting in a net purchase of 211,120 shares.
Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chimerix Inc Insider Transactions
David Jakeman Mailing Address
Above is the net worth, insider trading, and ownership report for David Jakeman. You might contact David Jakeman via mailing address: C/o Chimerix, Inc.,, 2505 Meridian Parkway, Suite 100, Durham Nc 27713.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
